Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Vitamin C for Sepsis and Septic Shock

View through CrossRef
Background: Sepsis remains a leading cause of death in the critically ill. The combination of thiamine, vitamin C, and hydrocortisone has recently emerged as a potential adjunctive therapy and supportive care for patients with sepsis and septic shock. Areas of Uncertainty: Several randomized and observational controlled trials evaluated the role of vitamin C in sepsis and septic shock. However, there are variabilities in the findings of these studies that led to a substantial global debate on incorporating vitamin C therapy in clinical practice. Data Sources: A PubMed and Embase English language literature search through April 2021 was performed using the following terms: ascorbic acid, vitamin C, corticosteroid, hydrocortisone, thiamine, HAT, sepsis, and shock. Citations, including controlled trials, observational studies, review articles, guidelines, and consensus statements, were reviewed. The risk of bias for each clinical study was systematically evaluated. Relevant clinical data focusing on efficacy, safety, and special considerations regarding the use of vitamin C with and without thiamine and hydrocortisone in sepsis and septic shock were narratively summarized. Results: The most commonly used vitamin C dosing in sepsis and septic shock is 1.5 g every 6 hours with and without thiamine and hydrocortisone. Current literature is limited because of heterogeneity in vitamin C regimen used, initiation time, and duration of treatment. This limitation led to variability in outcomes evaluated. Vitamin C decreases proinflammatory mediators and slows the progression of endothelial injury in severe sepsis. There is an inconsistency between randomized controlled trials and observational controlled trials regarding mortality, resolution in organ failure, hospital and intensive care unit length of stay findings with the use of vitamin C in septic shock. Vitamin C seems to be safe in comparison with placebo. Conclusions: Future studies with consistent end points, initiation time with an emphasis on early initiation, and standard vitamin C dosing regimen are needed to determine the overall benefit of vitamin C in sepsis.
Title: Vitamin C for Sepsis and Septic Shock
Description:
Background: Sepsis remains a leading cause of death in the critically ill.
The combination of thiamine, vitamin C, and hydrocortisone has recently emerged as a potential adjunctive therapy and supportive care for patients with sepsis and septic shock.
Areas of Uncertainty: Several randomized and observational controlled trials evaluated the role of vitamin C in sepsis and septic shock.
However, there are variabilities in the findings of these studies that led to a substantial global debate on incorporating vitamin C therapy in clinical practice.
Data Sources: A PubMed and Embase English language literature search through April 2021 was performed using the following terms: ascorbic acid, vitamin C, corticosteroid, hydrocortisone, thiamine, HAT, sepsis, and shock.
Citations, including controlled trials, observational studies, review articles, guidelines, and consensus statements, were reviewed.
The risk of bias for each clinical study was systematically evaluated.
Relevant clinical data focusing on efficacy, safety, and special considerations regarding the use of vitamin C with and without thiamine and hydrocortisone in sepsis and septic shock were narratively summarized.
Results: The most commonly used vitamin C dosing in sepsis and septic shock is 1.
5 g every 6 hours with and without thiamine and hydrocortisone.
Current literature is limited because of heterogeneity in vitamin C regimen used, initiation time, and duration of treatment.
This limitation led to variability in outcomes evaluated.
Vitamin C decreases proinflammatory mediators and slows the progression of endothelial injury in severe sepsis.
There is an inconsistency between randomized controlled trials and observational controlled trials regarding mortality, resolution in organ failure, hospital and intensive care unit length of stay findings with the use of vitamin C in septic shock.
Vitamin C seems to be safe in comparison with placebo.
Conclusions: Future studies with consistent end points, initiation time with an emphasis on early initiation, and standard vitamin C dosing regimen are needed to determine the overall benefit of vitamin C in sepsis.

Related Results

To Determine The Association Of Serum Neopterin Levels In Sepsis
To Determine The Association Of Serum Neopterin Levels In Sepsis
Abstract ABSTRACT Background: Sepsis is a leading cause of death worldwide. Sepsis results in state of multiorgan dysfunction in the body. Early identification and appropri...
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
OBJECTIVES: Sepsis is defined as life-threatening organ dysfunction triggered by an underlying infection. A recent study noted that the overall sepsis-related mortality...
Vitamin D and the Immune System. When? Why? How?
Vitamin D and the Immune System. When? Why? How?
Vitamin D, called “the sunshine vitamin” is essential for the good functioning of the human body. Vitamin D generates its principal effects via the vitamin D receptor (VDR), a spec...
Predictors of Septic Shock Mortality at a Tertiary Hospital in Ethiopia: A Prospective Observational Study
Predictors of Septic Shock Mortality at a Tertiary Hospital in Ethiopia: A Prospective Observational Study
Abstract Background: Septic shock causes significant mortality, ranging from 30% to 50%, with a slight difference in developing and developed countries. There is insufficie...
Relationship between serum ferritin level and outcome of septic shock in children
Relationship between serum ferritin level and outcome of septic shock in children
Background Sepsis is a life-threatening organ dysfunction caused by dysregulation of the immune system against infection. Sepsis that leads to septic shock is one of the causes of ...
CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study
CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study
Abstract Introduction Patients suffering from sepsis are currently classified on a clinical basis (i.e., sepsis, severe sepsis, sept...
Infusion therapy for sepsis in patients with burns
Infusion therapy for sepsis in patients with burns
Background. Sepsis develops in 8-42.5 % of patients with burns and is the leading cause of death among them. The criteria for sepsis are suspected or documented infection and the p...

Back to Top